Nuveen, LLC Enanta Pharmaceuticals Inc Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen, LLC holds 164,760 shares of ENTA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164,760
Previous 44,885
267.07%
Holding current value
$1.99 Million
Previous $339,000
481.71%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENTA
# of Institutions
128Shares Held
19.4MCall Options Held
290KPut Options Held
61.7K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$25.6 Million0.11% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$25.5 Million10.78% of portfolio
-
Janus Henderson Group PLC London, X01.95MShares$23.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$22.3 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $250M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...